Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer

Cancer Detection and Prevention

Volumn 31, Issue 5, 2007, Pages 408-416

  Pechlivanis, Sonali ^a   Wagner, Kerstin ^a   Chang Claude, Jenny ^a   Hoffmeister, Michael ^a   Brenner, Hermann ^a   Försti, Asta ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Case control study; Colorectal cancer; Haplotype; IGF1; IGFBP3; Polymorphism

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 36448965588     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.10.001     Document Type: Article

References (42)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. version 2.0. Lyon: IARC Press, 2004 [cited 2007 June 21]. Available from: http://www-dep.iarc.fr/.
2. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000) 78-85
3. Bustin S.A., and Jenkins P.J. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 7 (2001) 447-454
4. Stewart C.E., and Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76 (1996) 1005-1026
5. Laban C., Bustin S.A., and Jenkins P.J. The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 14 (2003) 28-34
6. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002) 824-854
7. Harrela M., Koistinen H., Kaprio J., Lehtovirta M., Tuomilehto J., Eriksson J., et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98 (1996) 2612-2615
8. Holmes M.D., Pollak M.N., and Hankinson S.E. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11 (2002) 862-867
9. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
10. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
11. Gatchel J.R., and Zoghbi H.Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6 (2005) 743-755
12. Pearson C.E., Nichol Edamura K., and Cleary J.D. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6 (2005) 729-742
13. Morimoto L.M., Newcomb P.A., White E., Bigler J., and Potter J.D. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 1204-1211
14. Slattery M.L., Samowitz W., Curtin K., Ma K.N., Hoffman M., Caan B., et al. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 1206-1214
15. Giovannucci E., Haiman C.A., Platz E.A., Hankinson S.E., Pollak M.N., and Hunter D.J. Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 11 (2002) 1509-1510
16. Wong H.L., Delellis K., Probst-Hensch N., Koh W.P., Van Den Berg D., Lee H.P., et al. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 14 (2005) 144-151
17. Wagner K., Hemminki K., Israelsson E., Grzybowska E., Soderberg M., Pamula J., et al. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92 (2005) 133-140
18. Fletcher O., Gibson L., Johnson N., Altmann D.R., Holly J.M., Ashworth A., et al. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 2-19
19. Friedrichsen D.M., Hawley S., Shu J., Humphrey M., Sabacan L., Iwasaki L., et al. IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate 65 (2005) 44-51
20. Li L., Cicek M.S., Casey G., and Witte J.S. No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiol Biomarkers Prev 13 (2004) 497-498
21. Schildkraut J.M., Demark-Wahnefried W., Wenham R.M., Grubber J., Jeffreys A.S., Grambow S.C., et al. IGF1 (CA)19 repeat and IGFBP3-202 A/C genotypes and the risk of prostate cancer in Black and White men. Cancer Epidemiol Biomarkers Prev 14 (2005) 403-408
22. Miyao M., Hosoi T., Inoue S., Hoshino S., Shiraki M., Orimo H., et al. Polymorphism of insulin-like growth factor I gene and bone mineral density. Calcif Tissue Int 63 (1998) 306-311
23. Rosen C.J., Kurland E.S., Vereault D., Adler R.A., Rackoff P.J., Craig W.Y., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83 (1998) 2286-2290
24. Frayling T.M., Hattersley A.T., McCarthy A., Holly J., Mitchell S.M., Gloyn A.L., et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51 (2002) 2313-2316
25. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., Hofman A., et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 (2001) 637-642
26. Vaessen N., Janssen J.A., Heutink P., Hofman A., Lamberts S.W., Oostra B.A., et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 359 (2002) 1036-1037
27. Cubbage M.L., Suwanichkul A., and Powell D.R. Insulin-like growth factor binding protein-3. Organization of the human chromosomal gene and demonstration of promoter activity. J Biol Chem 265 (1990) 12642-12649
28. Canzian F., McKay J.D., Cleveland R.J., Dossus L., Biessy C., Rinaldi S., et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94 (2006) 299-307
29. Deal C., Ma J., Wilkin F., Paquette J., Rozen F., Ge B., et al. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86 (2001) 1274-1280
30. Le Marchand L., Kolonel L.N., Henderson B.E., and Wilkens L.R. Association of an exon 1 polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1319-1321
31. Vorwerk P., Yamanaka Y., Spagnoli A., Oh Y., and Rosenfeld R.G. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol Metab 83 (1998) 1392-1395
32. Brenner H., Chang-Claude J., Seiler C.M., Sturmer T., and Hoffmeister M. Does a negative screening colonoscopy ever need to be repeated?. Gut (2006)
33. Lilla C., Verla-Tebit E., Risch A., Jager B., Hoffmeister M., Brenner H., et al. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15 (2006) 99-107
34. Frank B., Shanmugam K.S., Beckmann L., Hemminki K., Brenner H., Hoffmeister M., et al. Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 15 (2006) 2002-2005
35. Clayton D. SNPHAP: a program for estimating frequencies of large haplotypes of SNPs [monograph on the Internet]. Cambridge: Cambridge Institute for Medical Research; version 1.3 [cited 2007 June 21]. Available from: http://www.gene.cimr.cam.ac.uk/clayton/software/snphap.txt.
36. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
37. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
38. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
39. Jerome L., Shiry L., and Leyland-Jones B. Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocr Relat Cancer 10 (2003) 561-578
40. Al-Zahrani A., Sandhu M.S., Luben R.N., Thompson D., Baynes C., Pooley K.A., et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1 and IGFBP3 and risk of breast cancer. Hum Mol Genet 15 (2006) 1-10
41. Rohrbacher M., Risch A., Kropp S., and Chang-Claude J. The A(-336C) insulin-like growth factor binding protein-3 promoter polymorphism is not a modulator of breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev 14 (2005) 289-290
42. Cheng I., Stram D.O., Penney K.L., Pike M., Le Marchand L., Kolonel L.N., et al. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J Natl Cancer Inst 98 (2006) 123-134